Skip to content
healthcare.dev

dg health lansoprazole

NDC 55910-307, Lansoprazole, capsule, delayed release, from Dolgencorp Inc.

Product NDC
55910-307
Status
Listed
Labeler
Dolgencorp Inc
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA202319
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55910-307 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LANSOPRAZOLE15 mg/1

Pharmacologic classes

Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
55910-307-01559100307011 BOTTLE in 1 CARTON (55910-307-01) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55910-307 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55910-307 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55910-307. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.